Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy
Authors:
- 1 August 2016
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (2) , 536-543.e4
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparisonJournal of Allergy and Clinical Immunology, 2013
- Oral and sublingual peanut immunotherapy is not ready for general useAllergy and Asthma Proceedings, 2013
- Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcomeClinical & Experimental Allergy, 2011
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic responseJournal of Allergy and Clinical Immunology, 2011
- Peanut allergy and anaphylaxisCurrent Opinion in Immunology, 2010
- Oral peanut immunotherapy in children with peanut anaphylaxisJournal of Allergy and Clinical Immunology, 2010
- Safety of a peanut oral immunotherapy protocol in children with peanut allergyJournal of Allergy and Clinical Immunology, 2009
- Reported food allergy to peanut, tree nuts and fruit: comparison of clinical manifestations, prescription of medication and impact on daily lifeAllergy, 2008
- Peanut and tree nut allergy in childhoodPediatric Allergy and Immunology, 2008
- The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut‐allergic childrenClinical & Experimental Allergy, 2000